Movano is trading 15.69% down at $7.50 on October 15 after Corvex disclosed an at-the-market program allowing up to $250 million in common-stock sales. - The October 14 disclosure prompted dilution concerns; sales may occur over time. - Proceeds are intended for working capital and general corporate purposes. - The healthcare sector was positive and major indexes were mixed, making the company-specific financing news the clearest identified catalyst.